Learn More
Invitrogen™ SERPINB9 Monoclonal Antibody (PI9-17)

Description
The human intracellular serpin proteinase inhibitor 9 (PI9) is the only human protein able to inhibit the activity of the serine protease granzyme B. Granzyme B is expressed by cytotoxic lymphocytes and induces rapid target cell apoptosis. PI9-17 Mab was selected after immunization with full length recombinant PI9 produced in Escherichia coli. No cross reactivity with other, homologous serpins (PI6, PI8 and PAI-2) was observed.
Specifications
Specifications
| Antigen | SERPINB9 |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Monoclonal |
| Clone | PI9-17 |
| Concentration | 250 μg/mL |
| Conjugate | Unconjugated |
| Formulation | Tissue culture supernatant with 0.7% BSA and 0.1% sodium azide |
| Gene | SERPINB9 |
| Gene Accession No. | P50453 |
| Gene Alias | BB283241; CAP3; CAP-3; Cytoplasmic antiproteinase 3; ovalbumin; peptidase inhibitor 9; PI9; PI-9; protease inhibitor 9 (ovalbumin type); serine (or cysteine) peptidase inhibitor, clade B, member 9; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 9; serine (or cysteine) proteinase inhibitor, clade B, member 9; serine protease inhibitor 6; serpin B9; serpin family B member 9; serpin peptidase inhibitor, clade B (ovalbumin), member 9; serpin peptidase inhibitor, clade B, member 9; SERPINB9; Spi6; testicular tissue protein Li 180 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.